Systemic inflammation and proinflammatory interleukin-17 signalling persist at the end of therapy in patients with metabolic syndrome and psoriasis, reducing the length of remission-Reference-Cited by-同舟云学术

Systemic inflammation and proinflammatory interleukin-17 signalling persist at the end of therapy in patients with metabolic syndrome and psoriasis, reducing the length of remission

Published:2015-11-18 Issue:2 Volume:174 Page:414-416
ISSN:0007-0963
Container-title:British Journal of Dermatology
language:en
Short-container-title:Br J Dermatol

Author:

Coimbra S.¹²,Oliveira H.³,Neuparth M.J.²,Proença J.B.²,Figueiredo A.³,Rocha-Pereira P.⁴,Santos-Silva A.¹

Affiliation:

1. UCIBIO@REQUIMTE; Departamento de Ciências Biológicas; Laboratório de Bioquímica; Faculdade de Farmácia (FFUP); Universidade do Porto; R. Jorge Viterbo Ferreira 228 4050-313 Porto Portugal

2. CESPU; Instituto de Investigação e Formação Avançada em Ciências e Tecnologias da Saúde; Gandra-PRD Portugal

3. Serviço de Dermatologia; Centro Hospitalar e Universitário de Coimbra; Universidade de Coimbra; Coimbra Portugal

4. Centro de Investigação em Ciências da Saúde (CICS); Universidade da Beira Interior; Covilhã Portugal

Funder

Fundação para a Ciência e a Tecnologia

Federación Española de Enfermedades Raras

CITS

Publisher

Wiley

Subject

Dermatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjd.14013/fullpdf

Reference15 articles.

1. Circulating adipokine levels in Portuguese patients with psoriasis vulgaris according to body mass index, severity and therapy;Coimbra;J Eur Acad Dermatol Venereol,2010

2. Impact of body mass index and obesity on clinical response to systemic treatment for psoriasis. Evidence from the Psocare project;Naldi;Dermatology,2008

3. C-reactive protein and leucocyte activation in psoriasis vulgaris according to severity and therapy;Coimbra;J Eur Acad Dermatol Venereol,2010

4. Principal determinants of the length of remission of psoriasis vulgaris after topical, NB-UVB, and PUVA therapy: a follow-up study;Coimbra;Am J Clin Dermatol,2013

5. Inflammatory markers of cardiovascular disease risk in Portuguese psoriatic patients: relation with narrow-band ultraviolet B and psoralen plus ultraviolet A;Coimbra;Int J Dermatol,2014

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Higher IL-9 Level is Associated with Psoriasis Vulgaris Complicated by Metabolic Syndrome;Clinical, Cosmetic and Investigational Dermatology;2023-08

2. Biologic Treatment in Combination with Lifestyle Intervention in Moderate to Severe Plaque Psoriasis and Concomitant Metabolic Syndrome: Rationale and Methodology of the METABOLyx Randomized Controlled Clinical Trial;Nutrients;2021-08-29

3. The Association of Metabolic Syndrome and Psoriasis: A Systematic Review and Meta-Analysis of Observational Study;Endocrine, Metabolic & Immune Disorders - Drug Targets;2020-05-31

4. IL-17A in Psoriasis and Beyond: Cardiovascular and Metabolic Implications;Frontiers in Immunology;2020-01-15

5. IL‐17 and its role in inflammatory, autoimmune, and oncological skin diseases: state of art;International Journal of Dermatology;2019-10-30